Abstract LB-139: Phase I trial of veliparib or mitomycin (MMC) + veliparib in patients with sporadic solid tumors screened for somatic deficiency in the Fanconi Anemia (FA) pathway. Conference

Villalona-Calero, Miguel A, Duan, Wenrui, Zhao, Weiqiang et al. (2013). Abstract LB-139: Phase I trial of veliparib or mitomycin (MMC) + veliparib in patients with sporadic solid tumors screened for somatic deficiency in the Fanconi Anemia (FA) pathway. . CANCER RESEARCH, 73(8_Supplement), lb-139-lb-139. 10.1158/1538-7445.am2013-lb-139

cited authors

  • Villalona-Calero, Miguel A; Duan, Wenrui; Zhao, Weiqiang; Shilo, Konstantin; Ji, Jiuping; Thurmond, Jennifer; Norris, Adam; Rose, Jeffrey; Layman, Rachel; Marshall, John; Bekaii-Saab, Tanios; Chen, Alice

authors

publication date

  • April 15, 2013

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • Biotechnology
  • Breast Cancer
  • Cancer
  • Clinical Research
  • Genetics
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • American Association for Cancer Research (AACR)

start page

  • lb-139-lb-139

volume

  • 73

issue

  • 8_Supplement